Cargando…
A Dendritic Cell-Activating Rv1876 Protein Elicits Mycobacterium Bovis BCG-Prime Effect via Th1-Immune Response
The widely administered tuberculosis (TB) vaccine, Bacillus Calmette-Guerin (BCG), is the only licensed vaccine, but has highly variable efficiency against childhood and pulmonary TB. Therefore, the BCG prime-boost strategy is a rational solution for the development of new TB vaccines. Studies have...
Autores principales: | Choi, Seunga, Choi, Han-Gyu, Back, Yong Woo, Park, Hye-Soo, Lee, Kang-In, Gurmessa, Sintayehu Kebede, Pham, Thuy An, Kim, Hwa-Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465531/ https://www.ncbi.nlm.nih.gov/pubmed/34572519 http://dx.doi.org/10.3390/biom11091306 |
Ejemplares similares
-
Mycobacterium tuberculosis Rv2005c Induces Dendritic Cell Maturation and Th1 Responses and Exhibits Immunotherapeutic Activity by Fusion with the Rv2882c Protein
por: Back, Yong Woo, et al.
Publicado: (2020) -
Mycobacterium tuberculosis Protein Rv3841 Activates Dendritic Cells and Contributes to a T Helper 1 Immune Response
por: Choi, Seunga, et al.
Publicado: (2018) -
Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses
por: Back, Yong Woo, et al.
Publicado: (2019) -
Mycobacterium tuberculosis Rv2882c Protein Induces Activation of Macrophages through TLR4 and Exhibits Vaccine Potential
por: Choi, Han-Gyu, et al.
Publicado: (2016) -
Priming with a Recombinant Pantothenate Auxotroph of Mycobacterium bovis BCG and Boosting with MVA Elicits HIV-1 Gag Specific CD8(+) T Cells
por: Chapman, Rosamund, et al.
Publicado: (2012)